Companies: 10,795·Total market cap: $144.5T
Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC

HKMPYOTCHealthcare● Active
$39.08
+$0.08(+0.21%)
Market Cap$4.3B
P/E Ratio
52W High$56.91
52W Low$31.8

Hikma Pharmaceuticals PLC(HKMPY)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · HKMPY · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$3.36B$3.13B$2.88B$2.52B$2.55B
Cost of Revenue$2.01B$1.71B$1.47B$1.28B$1.25B
Gross Profit$1.34B$1.42B$1.41B$1.24B$1.30B
Gross Margin %(computed)40.04%45.25%48.94%49.19%50.96%
Operating Expenses
R&D Expenses$0.15B$0.14B$0.15B$0.14B$0.14B
G&A Expenses$0.00B$0.57B$0.64B$0.51B$0.49B
Total Operating Expenses$0.72B$0.80B$1.04B$0.96B$0.72B
Operating Income$0.63B$0.61B$0.37B$0.28B$0.58B
Operating Margin %(computed)18.63%19.57%12.77%11.20%22.80%
Interest Income$0.01B$0.01B$0.01B$0.00B$0.03B
Interest Expense$0.11B$0.09B$0.09B$0.07B$0.07B
Income Before Tax$0.52B$0.45B$0.28B$0.23B$0.54B
Income Tax Expense$0.11B$0.09B$0.09B$0.04B$0.12B
Net Income$0.40B$0.36B$0.19B$0.19B$0.42B
Net Margin %(computed)12.00%11.48%6.61%7.47%16.49%
Per Share & EBITDA
EPS (Basic)$3.66$3.24$1.70$1.68$3.64
Wtd Avg Shares0.11B0.11B0.11B0.11B0.12B
EBITDA$0.84B$0.73B$0.56B$0.69B$0.77B
EBITDA Margin %(computed)24.96%23.25%19.44%27.33%30.00%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · B

深入了解Hikma Pharmaceuticals PLC

关于Hikma Pharmaceuticals PLC(HKMPY)损益表

Hikma Pharmaceuticals PLC(HKMPY)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,HKMPY实现营收$3.36B,毛利润$1.34B(毛利率40.04%),净利润$0.40B(净利率12.00%)。

常见问题

HKMPY · 4 问

Hikma Pharmaceuticals PLC(HKMPY)2025财年营收为$3.36B,同比up7.3%。

HKMPY revenueHKMPY salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09